ArticleCell chemical biology2017

Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease.

Juliane Totzke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.